Decoding Johnson & Johnson's Options Activity: What's the Big Picture?

Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE: JNJ) revealed 12 unusual trades.

Delving into the details, we found 16% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $219,995, and 8 were calls, valued at $824,755.

### Projected Price Targets

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $230.0 for Johnson & Johnson over the last 3 months.

### Volume & Open Interest Trends

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Johnson & Johnson's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson's whale activity within a strike price range from $150.0 to $230.0 in the last 30 days.

### Johnson & Johnson Call and Put Volume: 30-Day Overview

!Options Call Chart

### Largest Options Trades Observed:

**Symbol****PUT/CALL****Trade Type****Sentiment****Exp. Date****Ask****Bid****Price****Strike Price****Total Trade Price****Open Interest****Volume**JNJCALLTRADEBEARISH03/20/26$20.05$19.85$19.85$190.00$297.7K3.1K1.1KJNJCALLSWEEPBEARISH06/18/26$10.75$10.3$10.3$210.00$154.5K1.3K1.1KJNJCALLSWEEPBEARISH12/18/26$9.25$7.95$7.9$230.00$124.8K1.0K0JNJPUTTRADEBEARISH12/18/26$6.9$4.55$6.9$175.00$109.0K42158JNJCALLTRADEBEARISH03/20/26$43.9$41.6$42.24$165.00$101.3K78325

### About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

### Where Is Johnson & Johnson Standing Right Now?

- With a volume of 2,917,091, the price of JNJ is up 0.28% at $206.0.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 49 days.

### What Analysts Are Saying About Johnson & Johnson

1 market experts have recently issued ratings for this stock, with a consensus target price of $197.0.

**Unusual Options Activity Detected: Smart Money on the Move**

\\* Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Johnson & Johnson with a target price of $197.

<p>Financial giants have made a conspicuous bearish move on Johnson &amp; Johnson. Our analysis of options history for Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/JNJ">JNJ</a>) revealed 12 unusual trades.</p>
<p>Delving into the details, we found 16% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $219,995, and 8 were calls, valued at $824,755.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $230.0 for Johnson &amp; Johnson over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Johnson &amp; Johnson's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson &amp; Johnson's whale activity within a strike price range from $150.0 to $230.0 in the last 30 days. </p>
<h3>Johnson &amp; Johnson Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1764792076_0.png" alt="Options Call Chart" /></p>

<h3>Largest Options Trades Observed:</h3>
<p><table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$20.05</td>
<td>$19.85</td>
<td>$19.85</td>
<td>$190.00</td>
<td>$297.7K</td>
<td>3.1K</td>
<td>1.1K</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$10.75</td>
<td>$10.3</td>
<td>$10.3</td>
<td>$210.00</td>
<td>$154.5K</td>
<td>1.3K</td>
<td>1.1K</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$9.25</td>
<td>$7.95</td>
<td>$7.9</td>
<td>$230.00</td>
<td>$124.8K</td>
<td>1.0K</td>
<td>0</td>
</tr>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$6.9</td>
<td>$4.55</td>
<td>$6.9</td>
<td>$175.00</td>
<td>$109.0K</td>
<td>42</td>
<td>158</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$43.9</td>
<td>$41.6</td>
<td>$42.24</td>
<td>$165.00</td>
<td>$101.3K</td>
<td>783</td>
<td>25</td>
</tr>
</tbody>
</table></p>
<h3>About Johnson &amp; Johnson</h3>
<p>Johnson &amp; Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.</p>
<h3>Where Is Johnson &amp; Johnson Standing Right Now?</h3>
<ul>
<li>With a volume of 2,917,091, the price of JNJ is up 0.28% at $206.0. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 49 days.</li>
</ul>
<h3>What Analysts Are Saying About Johnson &amp; Johnson</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $197.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Johnson &amp; Johnson with a target price of $197. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Johnson &amp; Johnson options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>